Injection site selection for SubQ peptides
Where to inject peptides subcutaneously — abdomen, thigh, arm, glute — site rotation, lipohypertrophy avoidance, and local vs systemic considerations.
Updated May 7, 2026 · 5 min read
Subcutaneous (SubQ) injection places the peptide just under the skin, above the muscle layer. For most strength peptides, the absorption profile is similar across the standard SubQ sites — meaning site choice is mostly about comfort, accessibility, and rotation. There are exceptions: locally-acting peptides like BPC-157 for tendon work get injected near the target tissue, not for systemic distribution but for local concentration.
The four standard sites
Most SubQ injection guidance maps to four anatomical regions:
| Site | Pinch quality | Pain profile | Notes |
|---|---|---|---|
| Abdomen (2 inches lateral to navel) | Easy pinch in most users | Generally low | Primary site for daily injectors |
| Outer thigh (front-lateral) | Moderate pinch | Variable — quad-heavy users feel more | Good rotation site |
| Upper arm (back-lateral, posterior) | Hard to pinch one-handed | Low if site is right | Easier with help; awkward solo |
| Glute (upper-outer quadrant) | Easy pinch | Generally low | Good for larger volumes |
The abdomen is the most common primary site for daily injectors. Skin pinches easily, the SubQ layer is consistent, and you can see what you're doing. Most users rotate around an "abdominal grid" of four to eight spots over a week.
Why the abdomen is usually first choice
Several practical reasons:
- Visibility. You can see the injection site and your hand position
- Consistent SubQ depth. Even lean users have enough subcutaneous tissue 2 inches lateral to the navel to inject without hitting muscle
- Pinch is easy — gives you a clear target and reduces depth-misjudgment risk
- Rotation is straightforward — the abdomen has plenty of real estate for 4–8 distinct spots
- Low nerve density in the standard zone, reducing pain
Avoid the area within 2 inches of the navel (more vascular, more sensitive) and stay 1–2 inches away from any scars or stretch marks.
When to use other sites
| Reason | Site to consider |
|---|---|
| Daily injection — abdomen needs rest | Outer thigh, upper arm |
| Higher volume (over 40 units) | Glute, thigh — more SubQ depth |
| Localized BPC-157 for injury | Near (not into) the affected tissue |
| Privacy concerns / visible site | Outer thigh, glute |
| Insulin user already rotating abdomen | Add thigh and arm to the rotation |
Local injection — BPC-157 and TB-500 for injury
Some peptides have a documented local-action profile in addition to systemic effects. The reported pattern for tendon and joint work:
- Achilles tendon issue: SubQ into the calf, 1–2 inches from the painful tendon — not into the tendon itself
- Knee: SubQ into the surrounding soft tissue, lateral or medial to the joint
- Lower back: paraspinal SubQ — into the tissue beside the spine, not deep IM
- Shoulder: SubQ into the lateral or posterior deltoid area, not into the joint capsule
- Elbow: SubQ near the affected tendon attachment, not into the joint
The principle: the peptide needs to be near the target tissue but does not need to be inside it. Direct injection into a joint or tendon carries injection-trauma risk and is not standard self-administered protocol. Stay subQ.
For dosing detail see BPC-157 dosing protocols and TB-500 dosing protocols.
Site rotation
Repeated injection in the exact same spot causes problems:
- Lipohypertrophy: lumpy fatty tissue from repeated trauma. Visible bumps under skin
- Reduced absorption: scarred or hypertrophied tissue absorbs less reliably, making doses inconsistent
- Increased pain over time: the site becomes sensitized
- Bruising clusters: repeated puncture in the same spot accumulates small bleeds
Rotation prevents all of these. A practical rotation:
| Day | Site |
|---|---|
| Monday | Right abdomen, upper |
| Tuesday | Right abdomen, lower |
| Wednesday | Left abdomen, upper |
| Thursday | Left abdomen, lower |
| Friday | Right outer thigh |
| Saturday | Left outer thigh |
| Sunday | Glute or arm |
Each individual spot gets injected roughly once a week. That's enough rest for skin to recover and SubQ tissue to re-equilibrate. Mark spots on a body diagram if you tend to forget which side you used.
Spots to avoid
| Region | Why |
|---|---|
| Within 2 inches of navel | More vascular, more sensitive |
| Visible veins | Higher chance of intravenous administration, bruising |
| Bruised, red, or tender areas | Already inflamed; injection adds to it |
| Moles, scars, stretch marks | Tissue is structurally different; absorption can be unreliable |
| Areas with active skin condition | Eczema, infection — increases infection risk |
| Tight waistband or beltline | Rubbing on injection site causes irritation |
| Inner thigh | Higher nerve density, more pain |
How to mark a site
For users injecting twice daily or rotating heavily, marking helps:
- Body diagram on paper — check off each site as you use it
- Phone notes app — log site + date + time
- Photo of injection site week-over-week — can help spot lipohypertrophy early
The goal is consistency. If you can't reliably remember which side you used yesterday, write it down.
Site-specific technique notes
| Site | Specific tip |
|---|---|
| Abdomen | Pinch a generous fold; insert at 45 degrees with 8 mm needle, 90 degrees with 12.7 mm |
| Thigh | Inject sitting; relax the quad; pinch a clear fold of fat away from muscle |
| Glute | Stand with weight on the opposite leg — relaxes the target side |
| Arm | Get help if possible; one-handed pinch reduces accuracy |
For full step-by-step technique, see injection technique.
Local site reactions
Some redness, mild itching, or a small pink raised area at the injection site is common in the first hour. It usually resolves without treatment. Warning signs that warrant attention:
- Persistent redness expanding beyond the immediate site after 24 hours
- Warm, hard, painful lump at the site
- Fever or systemic symptoms
- Drainage or pus
These suggest infection or contamination. Stop injecting at that site, monitor, and seek medical attention if symptoms progress.